APA (7th ed.) Citation

HA, S., G, J., O, H., J, G., KA, H., J, C., . . . Z, K. (2025). Public Health Impact of Introducing a Pentavalent Vaccine Against Invasive Meningococcal Disease in the United States. PharmacoEconomics, 43(3), 311. https://doi.org/10.1007/s40273-024-01439-y

Chicago Style (17th ed.) Citation

HA, Shah, et al. "Public Health Impact of Introducing a Pentavalent Vaccine Against Invasive Meningococcal Disease in the United States." PharmacoEconomics 43, no. 3 (2025): 311. https://doi.org/10.1007/s40273-024-01439-y.

MLA (9th ed.) Citation

HA, Shah, et al. "Public Health Impact of Introducing a Pentavalent Vaccine Against Invasive Meningococcal Disease in the United States." PharmacoEconomics, vol. 43, no. 3, 2025, p. 311, https://doi.org/10.1007/s40273-024-01439-y.